 | ENTA Makes Notable Cross Below Critical Moving Average
nasdaq.com - January 14 at 3:26 PM |
 | Nathalie Adda Sells 12,536 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock
americanbankingnews.com - January 13 at 9:32 PM |
 | Enanta under pressure after SVB Leerink slashed price target
seekingalpha.com - January 13 at 4:09 PM |
 | What 10 Analyst Ratings Have To Say About Enanta Pharmaceuticals
markets.businessinsider.com - January 13 at 4:09 PM |
| Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target Cut to $80.00
americanbankingnews.com - January 13 at 9:18 AM |
| Enanta Pharmaceuticals (NASDAQ:ENTA) Shares Down 3.9%
americanbankingnews.com - January 11 at 1:48 PM |
| Enanta Pharmaceuticals rises on pipeline updates for 2022
seekingalpha.com - January 6 at 7:27 PM |
 | Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 9:26 AM |
| Enanta Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 9:11 AM |
| Enanta Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
seekingalpha.com - December 3 at 11:44 AM |
| Enanta Pharmaceuticals Reaches Analyst Target Price
nasdaq.com - November 29 at 1:10 PM |
|
| Health Check: How Prudently Does Enanta Pharmaceuticals (NASDAQ:ENTA) Use Debt?
finance.yahoo.com - November 25 at 8:23 AM |
| Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
finance.yahoo.com - November 22 at 8:13 PM |
| Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - November 22 at 8:13 PM |
 | Enanta Pharmaceuticals's Earnings: A Preview
benzinga.com - November 19 at 5:54 PM |
| Is a Surprise Coming for Enanta Pharmaceuticals (ENTA) This Earnings Season?
finance.yahoo.com - November 19 at 12:53 PM |
| Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program
finance.yahoo.com - November 18 at 8:38 PM |
| Enanta Pharmaceuticals to Host Conference Call on November 22 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021
finance.yahoo.com - November 15 at 6:55 PM |
| Enanta Pharma Reports Positive Data From Phase 1b Studies Of EDP-514 - Quick Facts
markets.businessinsider.com - November 12 at 9:24 AM |
| Enanta Pharmaceuticals Reports Positive Final Data from its Phase 1b Studies of EDP-514, a Novel Hepatitis B Virus Core Inhibitor
finance.yahoo.com - November 12 at 9:24 AM |
| Notable Enanta Pharmaceuticals Insider Trades $1.3M In Company Stock
finance.yahoo.com - November 3 at 6:02 PM |
| Enanta Plans To Start Human Trials For Its COVID-19 Candidate In 2022
finance.yahoo.com - October 19 at 5:50 PM |
| Enanta Pharmaceuticals Presents New Data for EDP-235, its Lead Oral Protease Inhibitor Designed for the Treatment of COVID-19, at the ISIRV–WHO Virtual Conference 2021
finance.yahoo.com - October 19 at 7:48 AM |
| Senior VP And Chief Medical Officer Of Enanta Pharmaceuticals Trades $2.0M In Company Stock
benzinga.com - October 14 at 1:30 PM |
| Enanta Pharmaceuticals (ENTA) Moves 10.6% Higher: Will This Strength Last?
finance.yahoo.com - October 8 at 1:43 PM |
| Where Enanta Pharmaceuticals Stands With Analysts
markets.businessinsider.com - October 7 at 2:30 PM |
| Enanta Pharmaceuticals Inc Shares Near 52-Week High - Market Mover
nasdaq.com - October 6 at 2:06 PM |
| New Preclinical Data for EDP-235, Enanta’s Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19, to be Presented at ISRIV-WHO Virtual 2021 Conference: COVID-19, Influenza and RSV: Surveillance-Informed Prevention and Treatment
finance.yahoo.com - October 6 at 2:06 PM |
| Enanta Pharmaceuticals to Present at the H.C. Wainwright 2nd Annual Hepatitis B Virus Virtual Conference
finance.yahoo.com - October 5 at 10:30 AM |
| Enanta To Discontinue Internal Development Of NASH Candidates
finance.yahoo.com - October 5 at 12:28 AM |
| Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs
finance.yahoo.com - October 4 at 12:00 PM |
| Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021
finance.yahoo.com - October 1 at 9:43 AM |
| Enanta Pharmaceuticals to Participate in Investor Conferences in September
finance.yahoo.com - September 7 at 11:25 AM |
|
| Enanta Pharmaceuticals Inc Shares Close in on 52-Week High - Market Mover
nasdaq.com - August 28 at 6:06 PM |
| Enanta Pharmaceuticals Elects Yujiro S. Hata to its Board of Directors
finance.yahoo.com - August 23 at 8:25 AM |
| Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-721, Its Oral Hepatitis B Virus RNA Destabilizer
finance.yahoo.com - August 16 at 7:28 AM |
| Those who invested in Enanta Pharmaceuticals (NASDAQ:ENTA) five years ago are up 97%
finance.yahoo.com - August 13 at 4:43 PM |
| Enanta Pharmaceuticals, inc (ENTA) Q3 2021 Earnings Call Transcript
finance.yahoo.com - August 6 at 10:05 AM |
| Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
finance.yahoo.com - August 5 at 6:16 PM |
| Enanta Pharmaceuticals Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19
finance.yahoo.com - August 5 at 8:16 AM |
| Enanta Pharmaceuticals to Host Conference Call on August 5 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2021
finance.yahoo.com - July 29 at 10:19 AM |
| Earnings Preview: Enanta Pharmaceuticals (ENTA) Q3 Earnings Expected to Decline
finance.yahoo.com - July 27 at 7:40 PM |
| Enanta Pharmaceuticals, Inc. Common Stock (ENTA)
nasdaq.com - July 17 at 6:50 PM |
 | Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical OfficerNathalie Adda, M.D.
marketwatch.com - July 16 at 10:57 PM |
| Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical Officer Nathalie Adda, M.D.
finance.yahoo.com - July 14 at 10:13 PM |
 | ENTA Jan 2022 55.000 call
uk.finance.yahoo.com - June 30 at 11:33 PM |
 | BRIEF-Enanta Pharmaceuticals Presents New Data For EDP-721
msn.com - June 23 at 5:38 AM |
 | Enanta Pharmaceuticals Presents New Data for EDP-721, an Oral Hepatitis B Virus RNA Destabilizer, at the European Association for the Study of the Liver (EASL) International ...
businesswire.com - June 23 at 5:38 AM |
| Enanta Pharmaceuticals Presents New Data for EDP-721, an Oral Hepatitis B Virus RNA Destabilizer, at the European Association for the Study of the Liver (EASL) International Liver Congress™
finance.yahoo.com - June 23 at 5:38 AM |
| BRIEF-Enanta Pharma Reports Positive Data From Phase 1B Study Of EDP-514, A Hepatitis B Virus Core Inhibitor
msn.com - June 22 at 5:33 PM |
